| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/10/2013 | WO2013004591A1 Micronized crystals of atorvastatin hemicalcium |
| 01/10/2013 | WO2013004370A1 Continuous flow production of gelatin nanoparticles |
| 01/10/2013 | WO2013004250A1 Chewing gum having sustained release of nicotine |
| 01/10/2013 | WO2013004243A1 A nicotine-containing chewing gum piece packed in a wrapping of laminate |
| 01/10/2013 | WO2013004234A2 Methods for producing liposomes |
| 01/10/2013 | WO2013004171A1 Use of c15-substituted andrographolide derivatives in preparation of anti-hepatitis b virus medicament |
| 01/10/2013 | WO2013004123A1 Ibuprofen chewable tablet |
| 01/10/2013 | WO2012158493A3 Compounds that bind to the erythropoietin receptor |
| 01/10/2013 | WO2012156999A4 Ready to use docetaxel formulation |
| 01/10/2013 | WO2012144789A3 Non-animal soft capsule shell composition having improved disintegration and shell hardness |
| 01/10/2013 | WO2012142362A3 Synthetic platelets |
| 01/10/2013 | WO2012140680A8 Nanotori of semiconductor material for use in diagnostics and in the anti-tumor therapy and process for the production thereof |
| 01/10/2013 | WO2012138076A3 Composition containing herbal extract mixture for prevention or treatment of gastrointestinal diseases |
| 01/10/2013 | WO2012129057A3 Ssh-2 (slingshot-2) inhibitors and methods for making and using them |
| 01/10/2013 | WO2012123963A3 A process for preparation of iloperidone and amorphous co- precipitate of iloperidone with pharmaceutically acceptable excipient |
| 01/10/2013 | WO2012121988A3 Methods for treating diseases using isoindoline compounds |
| 01/10/2013 | WO2012117115A3 Use of a viscoelastic fluid for producing a medicinal product for surgically treating the eye |
| 01/10/2013 | WO2012115772A3 Therapy for kidney disease and/or heart failure |
| 01/10/2013 | WO2012069658A8 Immunomodulatory compositions comprising hydralazine for the treatment of gastrointestinal disorders |
| 01/10/2013 | WO2011131370A8 Melt-granulated fingolimod |
| 01/10/2013 | WO2011130834A8 Non-intravenous dosage form comprising solid formulation of liquid biologically active agent and uses thereof |
| 01/10/2013 | WO2011117377A3 Compositions comprising brimonidine for the treatment of erythema |
| 01/10/2013 | US20130012916 Delivery of immunoglobulin variable domains and constructs thereof |
| 01/10/2013 | US20130012893 Toroidal pharmaceutical formulations |
| 01/10/2013 | US20130012593 Modified release formulations of memantine oral dosage forms |
| 01/10/2013 | US20130012584 Tranexamic Acid Formulations |
| 01/10/2013 | US20130012542 Injectable depot formulation comprising crystals of iloperidone |
| 01/10/2013 | US20130012478 Dosage forms of bisphosphonates |
| 01/10/2013 | US20130012385 Pesticides and uses thereof |
| 01/10/2013 | US20130011485 Magnetic nanomedicine for inhibiting/treating human prostate cancer |
| 01/10/2013 | US20130011484 Cannabinoid Receptor Binding Agents, Compositions, and Methods |
| 01/10/2013 | US20130011483 Formulations of mazindol |
| 01/10/2013 | US20130011482 Dual component medicament delivery system |
| 01/10/2013 | US20130011481 Pyrroloquinolinyl-Pyrrolidine-2,5-Dione Formulations and Methods for Preparing and Using Same |
| 01/10/2013 | US20130011480 Cytotoxic therapy by proton flux modulation |
| 01/10/2013 | US20130011479 Double-layer pharmaceutical formulations containing opioid agonists and antagonists |
| 01/10/2013 | US20130011478 Pharmacologically optimized multimodal drug delivery system for nordihydroguiaretic acid (ndga) |
| 01/10/2013 | US20130011477 Stable Pharmaceutical Composition of Imatinib |
| 01/10/2013 | US20130011476 Stable compositions of famotidine and ibuprofen |
| 01/10/2013 | US20130011475 Stable compositions of famotidine and ibuprofen |
| 01/10/2013 | US20130011474 Modified and immediate release formulations of memantine |
| 01/10/2013 | US20130011473 Preparation Method Of The Solid Formulation Of Clopidogrel Bisulfate |
| 01/10/2013 | US20130011472 Stable pharmaceutical composition and methods of using same |
| 01/10/2013 | US20130011471 Stable pharmaceutical composition and methods of using same |
| 01/10/2013 | US20130011470 Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof |
| 01/10/2013 | US20130011469 Krill oil and carotenoid composition, associated method and delivery system |
| 01/10/2013 | US20130011468 Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction |
| 01/10/2013 | US20130011467 Method of treating malignant solid tumors using transcatheter arterial chemoembolization (tace) |
| 01/10/2013 | US20130011466 Liposome encapsulating ammine-platinum complex at high concentration, and method for production of the liposome |
| 01/10/2013 | US20130011465 Composition and method for the treatment of diseases affected by apoptosis |
| 01/10/2013 | US20130011464 Drug carrier and drug carrier kit for inhibiting fibrosis |
| 01/10/2013 | US20130011463 Method and device for synovial cell-charged collagen membrane or gel |
| 01/10/2013 | US20130011462 Melt extruded nicotine thin strips |
| 01/10/2013 | US20130011461 Nicotine-containing chewing gum piece packed in a wrapping of laminate |
| 01/10/2013 | US20130011460 Drug-carrying contact lens and method for fabricating the same |
| 01/10/2013 | US20130011457 Antimicrobial polymers and methods of manufacture thereof |
| 01/10/2013 | US20130011455 Novel Carrier System for the Transport of Active Substances into the Skin |
| 01/10/2013 | US20130011453 Buffered microencapsulated compositions and methods |
| 01/10/2013 | US20130011452 Topical foam composition |
| 01/10/2013 | US20130011451 Footbed with non-denatured collagen |
| 01/10/2013 | US20130011449 Solid preparation |
| 01/10/2013 | US20130011448 System for improved delivery of gene modulating compounds |
| 01/10/2013 | US20130011447 Controlled release nanoparticulate compositions |
| 01/10/2013 | US20130011446 Ceramic composition for filling bone defects |
| 01/10/2013 | US20130011445 Polymer-agent conjugates, particles, compositions, and related methods of use |
| 01/10/2013 | US20130011444 Compositions and methods for overcoming resistance to tramadol |
| 01/10/2013 | US20130011443 Human respiratory syncytial virus vaccine |
| 01/10/2013 | US20130011442 Method for repair of articular cartilage defect and a device used therein |
| 01/10/2013 | US20130011441 TARGETED DELIVERY OF siRNA |
| 01/10/2013 | US20130011440 Method and device for depositing thin layers, especially for the production of multiple layers, nanolayers, nanostructures and nanocomposites |
| 01/10/2013 | US20130011344 Use of iminocyclitols as inhibitors of bacterial adherence to epithelial cells |
| 01/10/2013 | US20130011343 Chewing gum having sustained release of nicotine |
| 01/10/2013 | US20130011342 Surfactant-free, water-free formable composition and breakable foams and their uses |
| 01/10/2013 | US20130011339 Nanoparticle compositions comprising a lipid bilayer and associated methods |
| 01/10/2013 | US20130011333 Methods and Compositions for Nanoparticle-Mediated Cancer Cell-Targeted Delivery |
| 01/10/2013 | US20130011332 Frozen Compositions and Methods for Piercing a Substrate |
| 01/10/2013 | DE102011051653A1 Quellfähige Manteltablette Swellable coated tablet |
| 01/10/2013 | CA2845665A1 Swellable coated tablet |
| 01/10/2013 | CA2843854A1 Herpes virus vaccine and methods of use |
| 01/10/2013 | CA2841785A1 Compositions and methods for treatment of symptoms in parkinson's disease patients |
| 01/10/2013 | CA2841079A1 Oral delivery of enzymes by nanocapsules for targeted metabolism of alcohol or toxic metabolites |
| 01/10/2013 | CA2840983A1 Adhesive skin patch containing serotonin receptor antagonist drug |
| 01/10/2013 | CA2840977A1 Liposomes having useful n:p ratio for delivery of rna molecules |
| 01/10/2013 | CA2840965A1 Cationic oil-in-water emulsions |
| 01/10/2013 | CA2840913A1 Oil-in-water emulsions that contain nucleic acids |
| 01/10/2013 | CA2840907A1 Cannabinoid receptor binding agents, compositions and methods |
| 01/10/2013 | CA2840905A1 Formulations for wound therapy |
| 01/10/2013 | CA2839584A1 Pyrroloquinolinyl-pyrrolidine-2,5-dione formulations and methods for preparing and using same |
| 01/10/2013 | CA2838659A1 Darunavir combination formulations |
| 01/10/2013 | CA2837539A1 Darunavir formulations |
| 01/09/2013 | EP2543387A1 Mucosal vaccine |
| 01/09/2013 | EP2543385A1 Novel analgesics |
| 01/09/2013 | EP2543374A2 Pharmaceutical composition for the prevention or treatment of osteoarthritis containing rebamipide as an active ingredient |
| 01/09/2013 | EP2543373A1 Compound pharmaceutical composition of levoamlodipine |
| 01/09/2013 | EP2543366A1 Film preparation containing medicament with unpleasant taste |
| 01/09/2013 | EP2543364A1 Formulations of cetyl myristate and/or cetyl palmitate |
| 01/09/2013 | EP2543363A1 Sustained release pharmaceutical oral solid dosage forms of dronedarone or one of its pharmaceutically acceptable salts |
| 01/09/2013 | EP2543362A1 Sustained release pharmaceutical oral solid dosage form of dronedarone or one of its pharmaceutically acceptable salts |
| 01/09/2013 | EP2543361A1 Sustained release pharmaceutical oral solid dosage forms of dronedarone or one of its pharmaceutically acceptable salts |
| 01/09/2013 | EP2543360A1 Liposome-encapsulated bicelles and use thereof in diluted systems |